Volitionrx (VNRX) Income from Non-Controlling Interests (2020 - 2026)
Volitionrx's (VNRX) quarterly Income from Non-Controlling Interests came in at -$52868.0 in Q1 2025, up 49.47% YoY from -$35371.4 in Q1 2024, and up 17.2% on a QoQ basis from -$63854.0 in Q4 2024.
Volitionrx (VNRX) Income from Non-Controlling Interests (2020 - 2026) Analysis & Trends
Volitionrx (VNRX) has 5 years of Income from Non-Controlling Interests data on file, last reported at -$52868.0 in Q1 2025.
- Quarterly Income from Non-Controlling Interests rose 49.47% year-over-year to -$52868.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was -$89142.0 (up 57.28% YoY) and the FY2024 annual result came in at -$290149.0, up 18.95% from the prior year.
- Income from Non-Controlling Interests grew to -$52868.0 in Q1 2025, from -$63854.0 in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of $94092.0 in Q4 2022 to a low of -$104617.0 in Q1 2024.
- A 4-year average of -$3285.8 and a median of -$47049.0 in 2024 frame the typical range for Income from Non-Controlling Interests.
- The widest YoY moves for Income from Non-Controlling Interests: up 211.17% in 2023, down 219.6% in 2023.
- Tracing VNRX's Income from Non-Controlling Interests over 4 years: stood at $94092.0 in 2022, then sank by 207.82% to -$101450.0 in 2023, then jumped by 37.06% to -$63854.0 in 2024, then gained by 17.2% to -$52868.0 in 2025.
- The last three Income from Non-Controlling Interests figures came in at -$52868.0 (Q1 2025), -$63854.0 (Q4 2024), and -$47049.0 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -500,000.00 |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 13.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 2.32 Mn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 900,000.00 |
| 10 | Volitionrx | 1.22 Mn | -1.58 Mn | - | 10,784.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10,784.00 |
| Jun 30, 2025 | -29,992.00 |
| Mar 31, 2025 | -52,868.00 |
| Dec 31, 2024 | -63,854.00 |
| Sep 30, 2024 | -47,049.00 |
| Jun 30, 2024 | 74,629.00 |
| Mar 31, 2024 | -104,617.00 |
| Dec 31, 2023 | -101,450.00 |
| Sep 30, 2023 | -82,887.00 |
| Jun 30, 2023 | 80,298.00 |
| Mar 31, 2023 | 93,361.00 |
| Dec 31, 2022 | 94,092.00 |
| Sep 30, 2022 | 69,305.00 |
| Jun 30, 2022 | 82,302.00 |
| Mar 31, 2022 | -83,977.00 |
| Sep 30, 2020 | 8,050.00 |
| Jun 30, 2020 | 5,779.00 |
| Mar 31, 2020 | 9,567.00 |